Publications
Publications
- August 2024
- HBS Case Collection
Sky Therapeutics: Innovating in Digital Therapeutics
By: Satish Tadikonda, Olivia Reszczynski and William Marks
Abstract
Shad Faraz and Alex Youssef were intrigued by the opportunities in the relatively new area of Digital Therapeutics. Despite initial successes, early entrants had struggled with reimbursement and revenue-predictability challenges. However, venture investors still continued to be enthusiastic about the space, prompting Faraz and Youssef to dive headfirst into the world of entrepreneurship and found Sky Therapeutics. Although their decision to pursue their startup full-time was exciting, they also needed to tackle pressing questions and unique challenges around the right clinical problem to target and with what technological and behavioral mechanism. Would the digital therapeutics space flourish or flop, and how would that affect Sky's prospects?
Keywords
Business Startups; Entrepreneurship; Mission and Purpose; Health Care and Treatment; Technological Innovation; Business Strategy; Health Industry; Technology Industry
Citation
Tadikonda, Satish, Olivia Reszczynski, and William Marks. "Sky Therapeutics: Innovating in Digital Therapeutics." Harvard Business School Case 825-071, August 2024.